Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

34

US Previously Marketed

8

Possibly Marketed Outside US

6

US Approved OTC

4

Other

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Acetylcholinesterase

4

Adrenergic receptor alpha-2

3

Iron

3

Kappa opioid receptor

3

Adrenergic receptor alpha-1

2

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

40

Phase III

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1921

13

1952

5

Unknown

5

1995

2

2015

2

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Unknown

4

Breast cancer

3

Cystic fibrosis

3

Advanced colorectal cancer

2

Allergic conjunctivitis

2

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

22

Palliative

12

Secondary

10

Curative

8

Preventing

8

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Penetrant

16

CNS Active

11

CNS Non-penetrant

2

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Burroughs Wellcome Fund

2

BASF

1

Black, J.

1

Charpentier, P. at Rhône-Poulenc

1

Childs, A.F.|Davies, D.R.|Green, A.L.|Rutland, J.P.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

44

Protein

3

Concept

2

Polymer

2

Mixture

1

All Match

Any Match

Exclude Selected

Exclude Selected

INN Stem

Chemical substance(-ine)

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

53

WHO-VATC

53

FDA UNII

52

WHO-ATC

52

DRUG BANK

51

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

VARIOUS

50

ALIMENTARY TRACT AND METABOLISM

5

RESPIRATORY SYSTEM

5

CARDIOVASCULAR SYSTEM

4

DERMATOLOGICALS

4

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ALL OTHER THERAPEUTIC PRODUCTS

50

OPHTHALMOLOGICALS

4

COUGH AND COLD PREPARATIONS

3

ANTISEPTICS AND DISINFECTANTS

2

DRUGS FOR CONSTIPATION

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ALL OTHER THERAPEUTIC PRODUCTS

49

EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS

3

ANTISEPTICS AND DISINFECTANTS

2

DRUGS FOR CONSTIPATION

2

OTHER OPHTHALMOLOGICALS

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Antidotes

29

Detoxifying agents for antineoplastic treatment

8

Drugs for treatment of hyperkalemia and hyperphosphatemia

5

Medical gases

4

Expectorants

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

38

Salts, Hydrates, Esters, etc.

14

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "VATC|ALL OTHER THERAPEUTIC PRODUCTS" in comments (approximate match)

Showing 51 - 53 of 53 results

First page
Previous page
6
Next page disabled
Next page disabled

GLUCARPIDASE

2GFP9BJD79

Subunit 1 (393) Similarity Search Subunit 2 (393) Similarity Search

Export Data
Sequence Search

Subunit 1 (393) Similarity Search Subunit 2 (393) Similarity Search

Status:

Other

Class:

PROTEIN

COLESTILAN CHLORIDE

VSI302RYSR

Export Data

Status:

Other

Class:

POLYMER

SUCROFERRIC OXYHYDROXIDE

87PZU03K0K

Status:

Other

Class:

CONCEPT

Showing 51 - 53 of 53 results

First page
Previous page
6
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1